ASX - By Stock
|
WHK |
Re:
Ann: $2.0M Placement to Support Growth in AI based Cybersecurity
|
|
EarlRet
|
23 |
10K |
8 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
23
|
10K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Announces CEO Departure
|
|
EarlRet
|
92 |
33K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
92
|
33K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
EarlRet
|
2.4K |
1.1M |
6 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
AD8 |
Re:
ATH
|
|
EarlRet
|
28 |
8.9K |
2 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
28
|
8.9K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
EarlRet
|
605 |
224K |
1 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
605
|
224K
|
1
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Quarterly Activities Report and Appendix 4C - quarterly
|
|
EarlRet
|
13 |
8.1K |
10 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
13
|
8.1K
|
10
|
|
ASX - By Stock
|
WHK |
Re:
MST Access Valuation: $0.75
|
|
EarlRet
|
20 |
12K |
4 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
20
|
12K
|
4
|
|
ASX - By Stock
|
TD1 |
Re:
Ann: India Market Update
|
|
EarlRet
|
141 |
33K |
5 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
141
|
33K
|
5
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Quarterly Activities Report and Appendix 4C - quarterly
|
|
EarlRet
|
27 |
13K |
4 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
27
|
13K
|
4
|
|
ASX - By Stock
|
4DS |
Re:
Ann: 4DS Technical Update
|
|
EarlRet
|
487 |
180K |
9 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
487
|
180K
|
9
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $32.5 MILLION PLACEMENT TO FAST TRACK BIG SANDY DEVELOPMENT
|
|
EarlRet
|
190 |
83K |
12 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
190
|
83K
|
12
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
EarlRet
|
195 |
78K |
9 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
195
|
78K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
EarlRet
|
155 |
59K |
5 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
155
|
59K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
EarlRet
|
195 |
78K |
6 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
195
|
78K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
EarlRet
|
195 |
78K |
3 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
195
|
78K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
EarlRet
|
195 |
78K |
8 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
195
|
78K
|
8
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Preliminary Final Report
|
|
EarlRet
|
12 |
5.2K |
2 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
12
|
5.2K
|
2
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Quarterly Activities Report and Appendix 4C - quarterly
|
|
EarlRet
|
19 |
9.0K |
10 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
19
|
9.0K
|
10
|
|
ASX - By Stock
|
SBW |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
EarlRet
|
11 |
2.7K |
2 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
11
|
2.7K
|
2
|
|
ASX - By Stock
|
SBW |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
EarlRet
|
11 |
2.7K |
0 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
11
|
2.7K
|
0
|
|
ASX - By Stock
|
WHK |
Re:
Cyber Security
|
|
EarlRet
|
7 |
4.4K |
10 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
7
|
4.4K
|
10
|
|
ASX - By Stock
|
9SP |
Re:
9SP General Discussion
|
|
EarlRet
|
720 |
187K |
1 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
720
|
187K
|
1
|
|
ASX - By Stock
|
9SP |
Re:
9SP General Discussion
|
|
EarlRet
|
720 |
187K |
1 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
720
|
187K
|
1
|
|
ASX - By Stock
|
9SP |
Re:
9SP General Discussion
|
|
EarlRet
|
720 |
187K |
1 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
720
|
187K
|
1
|
|
ASX - By Stock
|
AMS |
Re:
Ann: AMS Confirm Guidance, AGM Presentation
|
|
EarlRet
|
82 |
25K |
4 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
82
|
25K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
EarlRet
|
155 |
59K |
4 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
155
|
59K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Magsense trialling
|
|
EarlRet
|
7 |
3.0K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
7
|
3.0K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Magsense trialling
|
|
EarlRet
|
7 |
3.0K |
9 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
7
|
3.0K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
EarlRet
|
155 |
59K |
8 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
155
|
59K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
EarlRet
|
5.5K |
1.9M |
9 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
EarlRet
|
5.5K |
1.9M |
21 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
21
|
|
ASX - By Stock
|
9SP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
EarlRet
|
20 |
6.6K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
20
|
6.6K
|
4
|
|
ASX - By Stock
|
DTS |
Re:
Ann: Suspension from Official Quotation
|
|
EarlRet
|
113 |
25K |
1 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
113
|
25K
|
1
|
|
ASX - By Stock
|
9SP |
Re:
9SP General Discussion
|
|
EarlRet
|
720 |
187K |
3 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
720
|
187K
|
3
|
|
ASX - By Stock
|
92E Notices |
Re:
New Investors Information 92E
|
|
EarlRet
|
367 |
256K |
4 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
367
|
256K
|
4
|
|
ASX - By Stock
|
92E Notices |
Re:
New Investors Information 92E
|
|
EarlRet
|
367 |
256K |
4 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
367
|
256K
|
4
|
|
ASX - By Stock
|
DTS |
Re:
Ann: DRAGONTAIL SCHEME IMPLEMENTED
|
|
EarlRet
|
11 |
3.5K |
0 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
11
|
3.5K
|
0
|
|
ASX - By Stock
|
92E |
Re:
Ann: Elevated Radioactivity Intersected at the Gemini Project
|
|
EarlRet
|
90 |
31K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
90
|
31K
|
1
|
|
ASX - By Stock
|
PCK |
Re:
Ann: PainChek Infant study published in Lancet Digital Health
|
|
EarlRet
|
54 |
12K |
1 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
54
|
12K
|
1
|
|
ASX - By Stock
|
WHK |
Re:
Ann: U.S. Federal Cyber Risk Radar Contract Renewed
|
|
EarlRet
|
8 |
4.2K |
12 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
8
|
4.2K
|
12
|
|
ASX - By Stock
|
WHK |
Re:
Ann: U.S. Federal Cyber Risk Radar Contract Renewed
|
|
EarlRet
|
8 |
4.2K |
8 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
8
|
4.2K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion and Patrys collaborate on new cancer imaging agents
|
|
EarlRet
|
60 |
25K |
2 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
60
|
25K
|
2
|
|
ASX - By Stock
|
TRJ |
Re:
Will buy around 1.5
|
|
EarlRet
|
22 |
10K |
0 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
22
|
10K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
EarlRet
|
122 |
28K |
1 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
122
|
28K
|
1
|
|
ASX - By Stock
|
TRJ |
Re:
Will buy around 1.5
|
|
EarlRet
|
22 |
10K |
0 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
22
|
10K
|
0
|
|
ASX - By Stock
|
ICE |
Re:
Ann: Appendix 4C Cash Flow Report
|
|
EarlRet
|
4 |
2.9K |
2 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
4
|
2.9K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
EarlRet
|
529 |
179K |
7 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
529
|
179K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
EarlRet
|
529 |
179K |
3 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
529
|
179K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
EarlRet
|
529 |
179K |
8 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
529
|
179K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
EarlRet
|
529 |
179K |
6 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
529
|
179K
|
6
|
|